Europe — EMA
Noradrenaline (Norepinephrine) Kabi (Noradrenaline Tartrate)
GNH USA supplies Noradrenaline (Norepinephrine), a vasopressor treating hypotension, septic shock and cardiac arrest.
Request sourcing
What is Noradrenaline Tartrate?
Norepinephrine, the active ingredient in Noradrenaline (Norepinephrine) Kabi, is a sympathomimetic presented as a sterile injection for intravenous use. It is employed in acute care to raise blood pressure in patients with hypotension, manage septic shock, and support circulation during cardiac arrest.
GNH USA supplies Noradrenaline (Norepinephrine) Kabi as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, intensive‑care units, and emergency departments worldwide. The company ensures regulatory compliance, cold‑chain logistics where required, and responsive customer service for global procurement.
What is Noradrenaline Tartrate used for?
Noradrenaline (Norepinephrine) Kabi is a vasopressor used in critical care to counteract low blood pressure.
- Hypotension: restores adequate arterial pressure in patients with acute hypotension. - Septic shock: improves systemic vascular resistance and organ perfusion in septic shock. - Cardiac arrest: provides essential vasoconstrictive support during resuscitation efforts.
What are the side effects of Noradrenaline Tartrate?
Common Side Effects: - Headache: mild to moderate pain often related to rapid blood pressure changes. - Tachycardia: increased heart rate due to beta‑1 stimulation. - Peripheral ischemia: reduced blood flow to extremities causing coldness or discoloration. - Nausea: gastrointestinal discomfort reported in some patients.
Serious or Rare Side Effects: - Myocardial ischemia: chest pain or infarction from excessive cardiac workload. - Severe hypertension: dangerously high blood pressure requiring immediate intervention. - Tissue necrosis at infusion site: extravasation can lead to local tissue damage. - Pulmonary edema: fluid accumulation in lungs due to rapid fluid shifts. - Cardiac arrest: paradoxical event in susceptible individuals.
What precautions apply to Noradrenaline Tartrate?
Noradrenaline (Norepinephrine) Kabi requires careful monitoring and specific handling to ensure safety. - Continuous blood pressure monitoring: adjust infusion rate to maintain target pressures. - Cardiac rhythm observation: watch for arrhythmias, especially tachyarrhythmias. - Central venous access: preferred for prolonged infusions to reduce extravasation risk. - Caution in uncontrolled hypertension: avoid rapid dose escalation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Noradrenaline Tartrate interact with?
Noradrenaline (Norepinephrine) Kabi may interact with several drug classes, requiring vigilance.
Major Interactions (Avoid): - MAO inhibitors: can precipitate hypertensive crisis. - Tricyclic antidepressants: additive vasoconstrictive effects may cause severe hypertension.
Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt expected tachycardia response. - Calcium channel blockers: can enhance hypotensive effects. - Vasodilators (e.g., nitroglycerin): may reduce the drug's efficacy, requiring dose adjustments.



